Comment by adamredwoods

This is why there is a fast-track to accelerate break-through treatments, which dostarlimab utilized (but stalled thanks to covid):

https://www.fda.gov/patients/learn-about-drug-and-device-app...

But, yeah, the FDA is all over the place.